Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
Aadi Bioscience | 3350 | 31. mar 2025 | 1.69 | +6.29 |
AAK | 6AA0 | 31. mar 2025 | 25.78 | -0.85 |
Aalberts NV | AACA | 31. mar 2025 | 31.44 | -2.24 |
Aallon Group | I74 | 31. mar 2025 | 10.10 | +2.85 |
AAP Implantate AG | AAQ1 | 31. mar 2025 | 1.56 | -10.34 |
AAR Corp. | ARZ | 31. mar 2025 | 52.90 | -19.05 |
AB Akola Group | YG4 | 31. mar 2025 | 1.06 | -0.93 |
AB Amber Grid | AMH | 31. mar 2025 | 1.17 | 0.00 |
AB Dynamics plc | 6DY | 31. mar 2025 | 21.00 | -5.41 |
AB Ignitis Grupe | IGV0 | 31. mar 2025 | 21.65 | +4.09 |
AB S.A. | 8B6 | 31. mar 2025 | 24.70 | -1.98 |
Ab Science | A8D | 31. mar 2025 | 1.32 | -1.79 |
ABACUS GRP UTS | EZO1 | 31. mar 2025 | 0.62 | -2.78 |
Abacus Mining & Exploration Corp. | DGV2 | 31. mar 2025 | 0.01 | 0.00 |
ABB Ltd | ABJA | 31. mar 2025 | 48.20 | -3.21 |
ABB LTD. CDR O.N. | ABJ3 | 31. mar 2025 | 18.00 | 0.00 |
Abbott Laboratories | ABL | 31. mar 2025 | 119.54 | -1.60 |
AbbVie Inc. | 4AB | 31. mar 2025 | 194.04 | +2.29 |
ABC | EK7 | 31. mar 2025 | 0.57 | +1.54 |
ABC Arbitrage | 9BA | 31. mar 2025 | 5.65 | +0.36 |
ABC-Mart Inc. | 5B8 | 31. mar 2025 | 17.00 | -1.16 |
AbCellera Biologics Inc. - | 8QQ | 31. mar 2025 | 1.97 | -7.35 |
Abcourt Mines, Inc. | AML | 31. mar 2025 | 0.03 | +3.33 |
ABEN MINERALS LTD | R26 | 31. mar 2025 | 0.03 | 0.00 |
Abercrombie & Fitch Company | AFT | 31. mar 2025 | 68.88 | -1.29 |
Aberdeen Asia-Pacificome Fund | 9J90 | 31. mar 2025 | 13.96 | -0.21 |
Aberdeen International Inc | A8H | 31. mar 2025 | 0.01 | 0.00 |
Aberdeen Standard European Logistics Income Plc | 5JX | 31. mar 2025 | 0.66 | 0.00 |
Aberforth Smaller Companies Trust PLC | 0KJ | 31. mar 2025 | 15.80 | -0.63 |
ABG Sundal Collier Holding | DAB | 31. mar 2025 | 0.62 | +0.33 |
|
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.